AI Tokens
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Common-Size Income Statement
Quarterly Data

Amgen Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Product sales 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of sales -28.21 -29.47 -33.39 -31.77 -33.73 -34.33 -37.70 -35.70 -40.61 -40.24 -44.96 -39.73 -27.58 -27.13 -29.42 -26.66 -25.46 -24.04 -27.24 -27.40 -25.46 -26.77 -26.65
Gross profit from product sales 71.79% 70.53% 66.61% 68.23% 66.27% 65.67% 62.30% 64.30% 59.39% 59.76% 55.04% 60.27% 72.42% 72.87% 70.58% 73.34% 74.54% 75.96% 72.76% 72.60% 74.54% 73.23% 73.35%
Other revenues 4.88 5.42 4.87 5.33 4.60 4.65 3.51 4.25 4.32 4.32 4.62 4.63 5.42 4.53 4.43 4.38 6.65 4.98 8.85 9.17 6.11 6.74 5.53
Research and development -21.36 -19.59 -20.92 -22.87 -20.79 -19.88 -18.87 -19.78 -17.79 -18.00 -18.87 -19.58 -16.48 -16.65 -18.10 -20.21 -17.83 -16.54 -16.73 -21.50 -22.50 -17.70 -17.29
Acquired in-process research and development 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -24.62 0.00
Selling, general and administrative -17.00 -18.30 -19.49 -20.84 -18.82 -19.28 -21.43 -21.55 -19.94 -22.20 -25.40 -29.03 -20.66 -19.36 -21.52 -23.99 -20.63 -21.13 -21.43 -22.72 -20.65 -22.64 -22.42
Other -0.77 -1.22 1.38 -0.81 -3.60 -0.88 -10.54 -0.70 -0.87 -0.14 -1.48 -0.06 -9.84 -1.23 -2.53 0.52 -0.08 -8.63 0.17 -0.81 0.13 -1.47 -1.09
Operating income 37.54% 36.85% 32.44% 29.04% 27.65% 30.28% 14.96% 26.51% 25.11% 23.74% 13.92% 16.23% 30.86% 40.16% 32.86% 34.04% 42.65% 34.64% 43.62% 36.74% 37.63% 13.54% 38.07%
Interest expense, net -6.61 -7.06 -7.99 -6.97 -7.50 -7.91 -9.18 -8.57 -9.52 -10.05 -11.58 -10.48 -11.59 -11.25 -9.29 -6.33 -5.90 -5.22 -5.15 -5.34 -4.68 -4.60 -5.10
Other income (expense), net 16.48 -0.77 0.91 -5.90 22.76 -4.49 19.28 -8.97 22.45 -3.82 -3.30 5.13 10.46 -4.76 35.31 -1.02 1.60 -5.05 -9.25 2.58 1.16 0.18 0.23
Other income (expense) 9.88% -7.82% -7.08% -12.87% 15.27% -12.40% 10.10% -17.54% 12.93% -13.87% -14.88% -5.35% -1.13% -16.01% 26.02% -7.36% -4.30% -10.27% -14.40% -2.76% -3.53% -4.42% -4.86%
Income (loss) before income taxes 47.41% 29.02% 25.36% 16.16% 42.91% 17.88% 25.06% 8.97% 38.04% 9.87% -0.96% 10.88% 29.73% 24.15% 58.88% 26.68% 38.35% 24.38% 29.23% 33.98% 34.10% 9.13% 33.21%
Provision for income taxes -8.32 -4.12 -3.22 -1.93 -7.72 -1.55 -3.09 -1.78 -3.32 -0.60 -0.63 -1.09 -3.31 -3.52 -10.28 -2.01 -3.99 -3.41 -3.47 -3.70 -4.29 -1.54 -3.77
Net income (loss) 39.10% 24.90% 22.13% 14.23% 35.20% 16.33% 21.97% 7.19% 34.72% 9.28% -1.59% 9.79% 26.42% 20.63% 48.60% 24.66% 34.36% 20.97% 25.75% 30.28% 29.81% 7.59% 29.43%

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The financial performance exhibits a period of significant margin volatility, characterized by a sharp contraction in gross profitability during 2023 and early 2024, followed by a consistent recovery phase through 2026. This cycle is mirrored in the operating income and net income figures, which experienced substantial troughs before returning to historical norms.

Gross Profitability and Cost of Sales
A stable cost of sales profile, ranging between 24% and 27% of product sales from 2021 to mid-2022, shifted abruptly starting in late 2023. Cost of sales peaked at 44.96% in March 2024, leading to a corresponding decline in gross profit from approximately 73% to a low of 55.04% in the same period. A steady recovery trend is observed thereafter, with cost of sales decreasing to 28.21% and gross profit returning to 71.79% by September 2026.
Operating Expenditure Trends
Research and development expenses remained relatively consistent, generally fluctuating between 16% and 23% of product sales, though a slight upward trend is noted toward the end of 2025. Selling, general, and administrative expenses showed more variance, peaking at 29.03% in December 2023 before entering a sustained downward trajectory, reaching a period low of 17.00% by September 2026, suggesting improved operational efficiency over time.
Operating Income and Bottom-Line Performance
Operating income experienced significant volatility, dropping from highs above 40% in 2022 to a low of 13.92% in March 2024. This decline aligns with the peak in cost of sales and SG&A expenses. However, a robust recovery is evident from 2024 onward, with operating income climbing back to 37.54% by the end of the analyzed period. Net income followed a similar pattern, including a notable net loss of 1.59% in March 2024, before rebounding to a peak of 39.10% in September 2026.
Non-Operating Items and Tax Impact
Interest expenses increased from approximately 5% of product sales in 2021 to peak levels around 11% in 2023, eventually stabilizing between 6% and 8%. The "Other income (expense), net" line item introduced extreme volatility to the pre-tax income, with substantial positive spikes observed in March 2023 (35.31%), September 2024 (22.45%), and September 2025 (22.76%), indicating the presence of significant non-operational gains that frequently offset operating pressures.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?